Integer Holdings Return on Tangible Equity 2010-2025 | ITGR
Current and historical return on tangible equity values for Integer Holdings (ITGR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Integer Holdings Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.08B | $-0.25B | -33.98% |
| 2025-03-31 | $0.08B | $-0.33B | -29.96% |
| 2024-12-31 | $0.12B | $-0.18B | -45.98% |
| 2024-09-30 | $0.11B | $-0.22B | -40.29% |
| 2024-06-30 | $0.11B | $-0.30B | -34.97% |
| 2024-03-31 | $0.10B | $-0.35B | -31.69% |
| 2023-12-31 | $0.09B | $-0.26B | -28.37% |
| 2023-09-30 | $0.08B | $-0.30B | -23.45% |
| 2023-06-30 | $0.07B | $-0.34B | -18.57% |
| 2023-03-31 | $0.07B | $-0.38B | -16.51% |
| 2022-12-31 | $0.07B | $-0.39B | -16.31% |
| 2022-09-30 | $0.07B | $-0.43B | -17.87% |
| 2022-06-30 | $0.08B | $-0.46B | -21.99% |
| 2022-03-31 | $0.09B | $-0.35B | -27.92% |
| 2021-12-31 | $0.10B | $-0.38B | -32.50% |
| 2021-09-30 | $0.09B | $-0.23B | -30.29% |
| 2021-06-30 | $0.10B | $-0.27B | -29.38% |
| 2021-03-31 | $0.07B | $-0.31B | -18.31% |
| 2020-12-31 | $0.08B | $-0.35B | -19.10% |
| 2020-09-30 | $0.07B | $-0.38B | -16.85% |
| 2020-06-30 | $0.07B | $-0.43B | -16.20% |
| 2020-03-31 | $0.11B | $-0.44B | -22.47% |
| 2019-12-31 | $0.10B | $-0.46B | -19.43% |
| 2019-09-30 | $0.11B | $-0.47B | -21.15% |
| 2019-06-30 | $0.20B | $-0.51B | -34.39% |
| 2019-03-31 | $0.18B | $-0.55B | -28.99% |
| 2018-12-31 | $0.17B | $-0.58B | -22.80% |
| 2018-09-30 | $0.20B | $-0.62B | -24.71% |
| 2018-06-30 | $0.10B | $-0.75B | -10.53% |
| 2018-03-31 | $0.08B | $-0.99B | -7.85% |
| 2017-12-31 | $0.07B | $-0.81B | -6.39% |
| 2017-09-30 | $0.02B | $-1.10B | -1.84% |
| 2017-06-30 | $0.02B | $-1.13B | -1.54% |
| 2017-03-31 | $0.01B | $-1.16B | -1.17% |
| 2016-12-31 | $0.01B | $-1.18B | -0.41% |
| 2016-09-30 | $-0.03B | $-1.20B | 2.33% |
| 2016-06-30 | $-0.04B | $-1.23B | 4.60% |
| 2016-03-31 | $-0.03B | $-1.23B | 5.94% |
| 2015-12-31 | $-0.01B | $-1.15B | 6.04% |
| 2015-09-30 | $0.03B | $0.22B | 15.70% |
| 2015-06-30 | $0.05B | $0.21B | 24.76% |
| 2015-03-31 | $0.05B | $0.19B | 28.87% |
| 2014-12-31 | $0.06B | $0.17B | 36.73% |
| 2014-09-30 | $0.05B | $0.15B | 38.86% |
| 2014-06-30 | $0.05B | $0.15B | 42.48% |
| 2014-03-31 | $0.05B | $0.13B | 50.83% |
| 2013-12-31 | $0.04B | $0.10B | 53.43% |
| 2013-09-30 | $0.02B | $0.08B | 41.58% |
| 2013-06-30 | $0.00B | $0.06B | 5.59% |
| 2013-03-31 | $0.00B | $0.04B | -14.95% |
| 2012-12-31 | $-0.01B | $0.02B | -30.38% |
| 2012-09-30 | $0.01B | $0.02B | 38.10% |
| 2012-06-30 | $0.02B | $0.02B | 81.55% |
| 2012-03-31 | $0.03B | $0.01B | 77.04% |
| 2011-12-31 | $0.03B | $0.01B | 82.93% |
| 2011-09-30 | $0.04B | $0.06B | 93.33% |
| 2011-06-30 | $0.04B | $0.05B | 130.16% |
| 2011-03-31 | $0.04B | $0.04B | 242.42% |
| 2010-12-31 | $0.03B | $0.02B | 2266.67% |
| 2010-09-30 | $0.02B | $0.01B | -160.00% |
| 2010-06-30 | $-0.01B | $-0.01B | 37.11% |
| 2010-03-31 | $-0.01B | $-0.02B | 33.61% |
| 2009-12-31 | $-0.01B | $-0.03B | 25.53% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $3.760B | $1.717B |
| Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.276B | 21.81 |
| Intuitive Surgical (ISRG) | United States | $171.420B | 71.05 |
| IDEXX Laboratories (IDXX) | United States | $52.185B | 54.31 |
| Edwards Lifesciences (EW) | United States | $45.166B | 29.93 |
| Alcon (ALC) | Switzerland | $42.434B | 28.68 |
| IQVIA Holdings (IQV) | United States | $31.605B | 17.86 |
| DexCom (DXCM) | United States | $31.439B | 47.16 |
| Mettler-Toledo (MTD) | United States | $26.632B | 31.61 |
| STERIS (STE) | Ireland | $24.008B | 25.55 |
| Waters (WAT) | United States | $16.995B | 23.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.710B | 0.00 |
| Hologic (HOLX) | United States | $15.113B | 16.37 |
| Penumbra (PEN) | United States | $9.693B | 70.81 |
| Sysmex ADR (SSMXY) | Japan | $8.813B | 28.00 |
| Globus Medical (GMED) | United States | $8.376B | 19.27 |
| Masimo (MASI) | United States | $8.156B | 27.45 |
| Teleflex (TFX) | United States | $5.287B | 8.53 |
| Glaukos (GKOS) | United States | $5.124B | 0.00 |
| TransMedics (TMDX) | United States | $4.470B | 67.94 |
| LivaNova (LIVN) | United Kingdom | $2.765B | 15.82 |
| Alphatec Holdings (ATEC) | United States | $2.326B | 0.00 |
| Veracyte (VCYT) | United States | $2.263B | 31.27 |
| PROCEPT BioRobotics (PRCT) | United States | $2.148B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.073B | 24.75 |
| Artivion (AORT) | United States | $2.069B | 104.40 |
| Elekta AB (EKTAY) | Sweden | $1.879B | 16.90 |
| Integra LifeSciences Holdings (IART) | United States | $1.073B | 6.15 |
| OPKO Health (OPK) | United States | $1.048B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.06 |
| Tandem Diabetes Care (TNDM) | United States | $0.750B | 0.00 |
| SiBone (SIBN) | United States | $0.656B | 0.00 |
| AxoGen (AXGN) | United States | $0.652B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.618B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.511B | 4.11 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.501B | 8.84 |
| OrthoPediatrics (KIDS) | United States | $0.492B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.413B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| Pacific Biosciences Of California (PACB) | United States | $0.363B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.348B | 8.85 |
| RxSight (RXST) | United States | $0.301B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.34 |
| Alpha Tau Medical (DRTS) | Israel | $0.276B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| CVRx (CVRX) | United States | $0.196B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.114B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.093B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| DarioHealth (DRIO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.80 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |